Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04022616

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
99 (estimated)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Conditions

Interventions

TypeNameDescription
OTHERSpecimen collectionSpecimens are obtained from patients who are being treated for breast malignancies.

Timeline

Start date
2010-06-04
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2019-07-17
Last updated
2026-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04022616. Inclusion in this directory is not an endorsement.

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients (NCT04022616) · Clinical Trials Directory